Key players in pancreatic cancer-stroma interaction: cancer-associated fibroblasts, endothelial and inflammatory cells

Pancreatic cancer(PC) is the most aggressive type of common cancers, and in 2014, nearly 40000 patients died from the disease in the United States. Pancreatic ductal adenocarcinoma, which accounts for the majority of PC cases, is characterized by an intense stromal desmoplastic reaction surrounding...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of gastroenterology : WJG Vol. 22; no. 9; pp. 2678 - 2700
Main Authors Nielsen, Michael Friberg Bruun, Mortensen, Michael Bau, Detlefsen, Sönke
Format Journal Article
LanguageEnglish
Published United States Baishideng Publishing Group Inc 07.03.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Pancreatic cancer(PC) is the most aggressive type of common cancers, and in 2014, nearly 40000 patients died from the disease in the United States. Pancreatic ductal adenocarcinoma, which accounts for the majority of PC cases, is characterized by an intense stromal desmoplastic reaction surrounding the cancer cells. Cancer-associated fibroblasts(CAFs) are the main effector cells in the desmoplastic reaction, and pancreatic stellate cells are the most important source of CAFs. However, other important components of the PC stroma are inflammatory cells and endothelial cells. The aim of this review is to describe the complex interplay between PC cells and the cellular and noncellular components of the tumour stroma. Published data have indicated that the desmoplastic stroma protects PC cells against chemotherapy and radiation therapy and that it might promote the proliferation and migration of PC cells. However, in animal studies, experimental depletion of the desmoplastic stroma and CAFs has led to more aggressive cancers. Hence, the precise role of the tumour stroma in PC remains to be elucidated. However, it is likely that a contextdependent therapeutic modification, rather than pure depletion, of the PC stroma holds potential for the development of new treatment strategies for PC patients.
Bibliography:Michael Friberg Bruun Nielsen;Michael Bau Mortensen;S?nke Detlefsen;Department of Pathology, Odense University Hospital, University of Southern Denmark;Department of Surgery, HPB Section, Odense University Hospital, University of Southern Denmark
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Author contributions: Nielsen MFB and Detlefsen S drafted the manuscript; and Mortensen MB revised the manuscript.
Correspondence to: Sönke Detlefsen, MD, PhD, Clinical Associate Professor, Consultant Pathologist, Department of Pathology, Odense University Hospital, University of Southern Denmark, 5000 Odense, Denmark. sonke.detlefsen@rsyd.dk
Telephone: +45-65414806 Fax: +45-65912943
ISSN:1007-9327
2219-2840
DOI:10.3748/wjg.v22.i9.2678